NCT06228599View on ClinicalTrials.gov

Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Pancreas Cancer
Interventions
OTHER

Treatment Plan

A matched treatment regimen will be administered for approximately 12 weeks based on recommendations made by the MTB.

Trial Locations (1)

53226

RECRUITING

Froedtert Hospital & the Medical College of Wisconsin, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER